(Q40552573)

21 September 2017

Enhanced cytotoxicity of rituximab following genetic and biochemical disruption of glycosylphosphatidylinositol anchored proteins (English)

1 reference

21 September 2017

1 reference

2

1 reference

21 September 2017

Nagaprasad Nagajothi

1

1 reference

PubMed ID

15160958

21 September 2017

Galina L Mukhina

series ordinal

3

1 reference

PubMed ID

15160958

21 September 2017

Robert A Brodsky

series ordinal

4

1 reference

21 September 2017

1 April 2004

1 reference

21 September 2017

1 reference

21 September 2017

45

1 reference

21 September 2017

795-799

1 reference

21 September 2017

4

1 reference

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

21 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001625700

Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001625700

Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001625700

The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001625700

Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001625700

Abnormalities of PIG-A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001625700

Paroxysmal nocturnal hemoglobinuria as a molecular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001625700

Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001625700

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001625700

In vitro and in vivo purging of B lymphoma cells from stem-cell products using anti-CD20 Abs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001625700

CD20-Directed Serotherapy in Patients With Multiple Myeloma: Biologic Considerations and Therapeutic Applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001625700

Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001625700

CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001625700

Relative contributions of decay accelerating factor (DAF), membrane cofactor protein (MCP) and CD59 in the protection of melanocytes from homologous complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190310001625700

10.1080/10428190310001625700

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

15160958